Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
March 16, 2023
Read More
Monte Rosa Therapeutics to Present at Upcoming Investor Conferences
February 3, 2023
Read More
Monte Rosa Therapeutics Outlines Progress Across Portfolio of Molecular Glue Degraders and Key Anticipated Milestones for 2023
January 9, 2023
Read More
Monte Rosa Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 4, 2023
Read More